ArnoldDLEmrichJF: Characterization of astrocytomas, meningiomas and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg, 74: 447–453, 1991.
2.
BergstromMEricsonK: PET study of methionine accumulation in gliomas and normal brain tissue; competition with branched chain amino acids. J Comput Assist Tomogr, 11: 208–213, 1987.
3.
BlackKLHawkinsRA: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg, 71: 342–346, 1989.
4.
BruhnHFrahmJGyngelML: Noninvasive differentiation of tumors with use of localized H-1 MR Spettroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology, 172: 541, 1989.
5.
ColemanREHoffmanJM: Clinical application of PET for evaluation of brain tumors. J Nucl Med, 32: 616–622, 1991.
6.
DoyleWKBudingerTF: Differentiation of cerebral radiation necrosis from tumor recurrence by 18 FDG and 82 Rb positron emission tomography. J Comp Assist Tomogr, 11: 563–570, 1987.
7.
FaliniACalabreseG: La spettroscopia in Risonanza Magnetica. Argomenti di Neurologia, 3: 219–232, 1993.
8.
HansonMWHoffmanGM: FDG PET in the early postoperative evaluation of patients with brain tumor. J Nucl Med, 31: 799, 1990.
9.
IshizuKSadatoN: Enhanced detection of brain tumors by 18F-Fluorodeoxyglucose PET with glucose loading. J Comput Assist Tomogr, 18: 12–15, 1994.
10.
MazziottaJC: The continuing challenge of primary brain tumor menagement: The contribution of positron emission tomography. Ann Neurol, 29: 345–346, 1991.
11.
O'TuamaLALa FranceND: Quantitative imaging of neutral amino acid transport by human brain tumors. J Cereb Blood Flow Metab, 7: 5517, 1987.
12.
RicciMPantanoP: SPECT con Tallio-201 nella diagnosi differenziale tra recidiva di tumore e radionecrosi: Risultati preliminare e proposta di una nuova tecnica. In Neuroradiologia, Ed del Centauro: 365–368, 1992.
13.
RosenBRBelliveauJW: Susceptibility contrast imaging of cerebral blood volume: Human experience. Magn Reson Med, 22: 293–299, 1991.
14.
ValkPEBudingerTF: PET of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg, 69: 830–838, 1988.
